The Dx–pH Measurement System is a revolutionary device that comfortably measures pH in the upper airway or esophagus. Prior to Restech’s introduction, it was difficult to detect reflux in the upper airway because previously available pH monitors were limited to measuring liquid reflux in the esophagus. Restech’s patented technology is the only commercial device available that is capable of measuring both liquid and aerosolized pH levels.
Gastric reflux in the upper airway, or laryngopharyngeal reflux (LPR), commonly takes an aerosolized form that cannot be measured using conventional technology. The miniaturized pH sensor at the tip of the Dx–pH Probe measures pH in the upper airway, making the Dx–pH System a valuable tool in determining the existence of LPR and its relationship to various patient symptoms.
The Dx–pH Measurement System is a simple tool for 24 to 48 hour ambulatory oropharyngeal pH testing. Guided by a blinking light-emitting diode (LED) in the probe tip, the physician visually positions the probe just behind the uvula in the oropharynx. Once placed, the single-channel Dx–pH Probe takes a pH reading twice per second and sends the data wirelessly from the attached Dx–Transmitter to the Dx–Recorder. Throughout the study, the patient inputs clinically relevant information (e.g. meals, symptoms, sleep) with the press of a button. Upon completion of the study, the pH data and patient information is downloaded from the SD memory card into the Dx–pH DataView software to be viewed, graphed, and printed.
The Restech sensor has been independently tested through the range of pH 1–13 for responsiveness and accuracy. Restech reliably reads both acidic and alkaline pH levels through both ends of this range with accuracy within 0.1 pH at any point over 24 hours. Unlike conventional pH probes, there is no drift in Restech’s reading.
The information provided by the Dx–pH Measurement System is important in determining the impact of laryngopharyngeal reflux (LPR) on a patient’s symptoms. This test provides a graphical representation of the pH activity over a 24 or 48-hour study. The data obtained is valuable as it relays information about the patient’s LPR patterns in a clear fashion.
When assessing patients for potential bile reflux and alkaline exposure, Restech uniquely measures real time alkaline pH. Acid reflux, weakly acid gastroesophageal reflux (WAGR), and alkaline reflux are also accurately measured with Restech.
Some ask “How is this is better than laryngoscopy?” With laryngoscopy, the physician can evaluate the severity of tissue damage but cannot determine whether it is the result of LPR, vocal strain, coughing, or another source.
The Restech pH system can integrate seamlessly into your practice flow. Download our sample flow chart to see how this could be a game-changer to your diagnostic process for reflux.
{{cta(‘cdeba905-83e6-453c-af06-981d5d49962c’)}}
Bree has been an integral part of Restech from the very beginning. She holds a Masters in Public Health from George Washington University, a BFA from The University of Kansas in Visual Communications, and is a National Board Certified Health & Wellness Coach. Her command of marketing, public health/health delivery systems, and human health behavior change gives her a unique perspective in developing effective marketing strategies for the company.
Physicians: Fill out the form below to complete your request to be added to the “Find-A-Doctor” map on restech.com
Thomas previously worked as a polysomnographic technologist in the Virginia Mason system, before moving into sales with Restech in 2007. After spending 9 years working with distributors across Europe, he was moved into an organizational role at the head office in Houston. In this capacity he works closely with sales and marketing to provide clinical support, manages clinical studies, and provides clinical perspectives on business development. In his spare time Thomas plays rugby for Houston Athletic Rugby Club.
Jeff has over 30 years of experience in the medical device industry and previously worked in sales at companies such as Encision Inc., Interventional Therapies, LLC, Boston Scientific, and United States Surgical Corporation. He has been working as the VP of Sales for Mederi Therapeutics since 2009 and now brings his extensive expertise to Restech. Jeff was part of the team that bridged the Mederi asset sale to Restech. His clinical knowledge of the Stretta and Secca technologies is invaluable. Jeff has three decades of physician relations experience that he brings to Restech as part of the leadership team.
Ray joined Restech in May 2018 as the Vice President for Sales. He has been in the medical device, and specifically in the GERD space for more than 18 years. Starting in sales at Sandhill Scientific pH diagnostics, he moved on to Curon Medical when Stretta and Secca were first introduced to the market. He then worked for Given Imaging when Curon closed operations. When Stretta was relaunced he joined Mederi as VP of Sales. Ray was instrumental in keeping Stretta alive and the customer based informed when Mederi ceased operation and assets were purchased by Restech. He is part of the leadership team directing all product sales for Restech. Ray graduated from Old Dominion University in Norfolk with a BS in Marketing and Business Administration.
Mark is a seasoned professional and Certified Public Accountant in Texas who brings a unique blend of creative vision and financial expertise to any leadership team. He worked as a Senior Executive for 15 years on a leadership team which grew a private equity backed cash logistics company performing at negative EBITDA on $100 million revenue into an international industry leader with superior profitability on revenue exceeding $1.5 billion. In addition, he spent 10 years as a Senior Manager at Price Waterhouse delivering results-oriented merger & acquisition, audit and strategic consulting services to middle market clientele including over 40 manufacturing, distribution, service, nonprofit and technology clients. Mark currently serves as a Chief Financial Officer and consulting CFO (seven years) providing in-house and outsourced CFO and transactional services to the middle market.
Larry is the CTO for Restech and holds a B.S. in Computer Science. He is a software architect specializing in remote patient monitoring, medical sensors, and clinical trial software. Larry holds a patent on massively distributed computing and has worked for a number of major software startup companies including Sybase, Oracle, and Teradata. Larry was also the co-founder of a startup to deliver advanced clinical pathways to patients using mobile devices and medical sensors. Larry is truly a pioneer and now a veteran in the deployment.
Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.
With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.
With over 20 years of executive experience in both the private and public sector, Debra brings a broad understanding of healthcare delivery system. With experience managing products aimed at wide scale disease and population management for 20 million subscribers, Debra has extensive experience in effectively and efficiently developing models of delivery that address specific health issues. Debra has also been involved in the legislative process and served as the elected President of the Independent Physician Association of California. Debra is dedicated to bringing tools to the healthcare market that improve and support the clinical process.